TORONTO, Feb. 2, 2018 /PRNewswire/ – Avicanna Inc. (“Avicanna“) is pleased to announce that its Colombian subsidiary Sativa Nativa S.A.S. (“Sativa Nativa“) has been issued a psychoactive cannabis Cultivation license and a

Share

TORONTO, Canada/January 29, 2018:   Avicanna Inc., (“Avicanna”) is pleased to announce the completion of its non-brokered private placement offering (the “Offering”) for units in Avicanna (each a “Unit”). Each Unit

Share
Marijuana Meds and Myths

At the end of June, more than 200,000 Canadians were registered to buy medical marijuana from more than 60 licensed Canadian producers. People use the drug to treat everything from

Share

This article was originally published on Benzinga, and adapted exclusively for HIGH TIMES. As a cannabis company, Avicanna did not know what the outcome would be when applying to be part of JLABS

Share
Meet Avicanna, The First Marijuana Company To Be Accepted Into Johnson & Johnson Innovation, JLABS @ Toronto

As a cannabis-focused company, Avicanna did not know what the outcome would be when it applied to be part of JLABS @ Toronto. Yet, the company was delighted to make

Share

Toronto ON – May • 2017— Avicanna Inc., a biotechnology company focused on innovative approaches and technologies in the medical cannabis sector, has recently completed its first round of financing

Share